The European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous ...

Intravenous immunoglobulin therapy (IVIG) is a critical treatment modality in the management of a spectrum of immunodeficiencies, autoimmune disorders, and inflammatory conditions.

The IVIG-induced lipogenesis was driven by F(ab’) 2 fragments and required the presence of sialylated glycans on immunoglobulin G (IgG). Investigators concluded that IVIG targeted immune cell ...

At Marshfield Children’s Hospital, Dr. Dolly Paw-ton, the facility dog, is helping make them happen. One Wausau family sees ...

Minor AEs are common with IVIG treatment and range from 2% to 25% per infusion. [24,25] The most commonly reported AE'-associated with Privigen® is headache, which occurs in 65% of patients.

A newborn survived a rare combination of Jka hemolytic disease and HDFN thanks to early diagnosis and aggressive treatment.

Similarly, kidney function declined more slowly in the IVIG group, with an average monthly drop in eGFR of just -0.4 ml/min, compared to -1.1 ml/min in the no-IVIG group. Although patient and graft ...

IVIG is employed in treating MIS-C due to the clinical parallels between MIS-C and Kawasaki disease; IVIG is a well-established therapy for mitigating the risk of coronary artery aneurysms . However, ...

Good evidence that intravenous immunoglobulin treatment within the first 10 days of symptoms reduces coronary artery abnormalities (heart damage) in children with Kawasaki disease. Kawasaki disease is ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...